Telithromycin and myasthenic crisis [4]

Clinical Infectious Diseases

Volumn 43, Issue 12, 2006, Pages 1621-1622

  Jennett, Alison M ^a,b   Bali, Doru ^b,c   Jasti, Pallavi ^b,c   Shah, Bhavish ^b,c   Browning, Linda A ^a,b  

^a DETROIT MEDICAL CENTER   (United States)

^b DETROIT RECEIVING HOSPITAL   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; DIPHENHYDRAMINE; GLYCOPYRRONIUM BROMIDE; IPRATROPIUM BROMIDE; METHYLPREDNISOLONE; MIDAZOLAM; PREDNISONE; PROPOFOL; PYRIDOSTIGMINE; SALBUTAMOL; SUXAMETHONIUM; TELITHROMYCIN; VECURONIUM;

ADULT; ANAPHYLAXIS; CASE REPORT; DISEASE EXACERBATION; DRUG DOSE INCREASE; DYSPNEA; ENDOTRACHEAL INTUBATION; FEMALE; HUMAN; HYPERTENSION; LETTER; MYASTHENIA GRAVIS; PLASMAPHERESIS; PRIORITY JOURNAL; RESPIRATORY FAILURE; SINUSITIS; VITAL SIGN;

ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; KETOLIDES; MIDDLE AGED; MYASTHENIA GRAVIS;

EID: 33845437989     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/509646     Document Type: Letter

References (6)

1. Nieman RB, Edelberg H, Caffe SE. Telithromycin and myasthenia gravis [letter]. Clin Infect Dis 2003; 37:1579.
2. Richman DP, Anius MA. Treatment of autoimmune myasthenia gravis. Neurology 2003; 61:1652-61.
3. Wittbrodt ET. Drugs and myasthenia gravis. Arch Intern Med 1997; 157:399-408.
4. Barrons RW. Drug-induced neuromuscular blockade and myasthenia gravis. Pharmacotherapy 1997; 17:1220-32.
5. Ketek (telithromycin) [package insert]. Kansas City, MO: Aventis, 2004.
6. Reuters. Aventis urges extreme caution with Ketek in patients with myasthenia gravis [editor's comments]. Clin Infect Dis 2003; 36:ii.